Madrigal Pharmaceuticals Stock Target Price and Analyst Consensus
| MDGL Stock | USD 487.78 0.48 0.1% |
The current analyst and expert consensus on Madrigal Pharmaceuticals is Strong Buy, with 10 strong buy opinions. The current projected Madrigal Pharmaceuticals target price consensus is 664.47 with 15 analyst opinions. Check out Macroaxis Advice on Madrigal Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.The most common way Madrigal Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Madrigal Pharmaceuticals executives and customers to further validate their buy or sell advice. Madrigal Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Madrigal Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 2.5861.
Lowest Forecast 604.66 | Highest Forecast 737.56 | Target Price 664.47 |
It's important to approach Madrigal Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Madrigal Pharmaceuticals Target Price Consensus
Madrigal target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Madrigal Pharmaceuticals' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 15 | Strong Buy |
Most Madrigal analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Madrigal stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Madrigal Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationMadrigal Pharmaceuticals Target Price Projection
Madrigal Pharmaceuticals' current and average target prices are 487.78 and 664.47, respectively. The current price of Madrigal Pharmaceuticals is the price at which Madrigal Pharmaceuticals is currently trading. On the other hand, Madrigal Pharmaceuticals' target price is what analysts think the stock is worth. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Madrigal Pharmaceuticals Market Quote on 10th of February 2026
Target Price
Analyst Consensus On Madrigal Pharmaceuticals Target Price
Madrigal Pharmaceuticals Analyst Ratings
Madrigal Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Madrigal Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Madrigal Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Madrigal Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Madrigal Pharmaceuticals price targets
Madrigal Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Madrigal Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Madrigal Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Madrigal Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Madrigal Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Madrigal Pharmaceuticals is a key component of Madrigal Pharmaceuticals valuation and have some predictive power on the future returns of a Madrigal Pharmaceuticals.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 90 shares | |
 | SRI Sustainable Growth Invested over 90 shares | |
 | ESG Investing Sold few shares | |
 | Millennials Best Invested over 90 shares | |
Check out Macroaxis Advice on Madrigal Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.